326 related articles for article (PubMed ID: 29239139)
1. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
2. Transgelin, a p53 and PTEN-Upregulated Gene, Inhibits the Cell Proliferation and Invasion of Human Bladder Carcinoma Cells in Vitro and in Vivo.
Tsui KH; Lin YH; Chang KS; Hou CP; Chen PJ; Feng TH; Juang HH
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31591355
[TBL] [Abstract][Full Text] [Related]
3. Topoisomerase inhibitors modulate gene expression of B-cell translocation gene 2 and prostate specific antigen in prostate carcinoma cells.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Chang PL; Chen WT; Juang HH
PLoS One; 2014; 9(2):e89117. PubMed ID: 24586533
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor-15: a p53- and demethylation-upregulating gene represses cell proliferation, invasion, and tumorigenesis in bladder carcinoma cells.
Tsui KH; Hsu SY; Chung LC; Lin YH; Feng TH; Lee TY; Chang PL; Juang HH
Sci Rep; 2015 Aug; 5():12870. PubMed ID: 26249737
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
6. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein 3 Is a Hypoxia-Upregulated Oncogene Enhancing Cell Invasion and Tumorigenesis in Human Bladder Carcinoma Cells.
Tsui KH; Hou CP; Chang KS; Lin YH; Feng TH; Chen CC; Shin YS; Juang HH
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813460
[TBL] [Abstract][Full Text] [Related]
8. The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway.
Wan W; Hou Y; Wang K; Cheng Y; Pu X; Ye X
Cell Death Dis; 2019 Mar; 10(3):248. PubMed ID: 30867411
[TBL] [Abstract][Full Text] [Related]
9. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
10. microRNA-21 Regulates Cell Proliferation and Migration and Cross Talk with PTEN and p53 in Bladder Cancer.
Lei M; Xie W; Sun E; Sun Y; Tian D; Liu C; Han R; Li N; Liu M; Han R; Liu L
DNA Cell Biol; 2015 Oct; 34(10):626-32. PubMed ID: 26230405
[TBL] [Abstract][Full Text] [Related]
11. L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells.
Chung LC; Tsui KH; Feng TH; Lee SL; Chang PL; Juang HH
Am J Physiol Cell Physiol; 2012 Feb; 302(4):C676-85. PubMed ID: 22116304
[TBL] [Abstract][Full Text] [Related]
12. USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer.
Man X; Piao C; Lin X; Kong C; Cui X; Jiang Y
J Exp Clin Cancer Res; 2019 Jun; 38(1):259. PubMed ID: 31200745
[TBL] [Abstract][Full Text] [Related]
13. Maspin is a PTEN-Upregulated and p53-Upregulated Tumor Suppressor Gene and Acts as an HDAC1 Inhibitor in Human Bladder Cancer.
Lin YH; Tsui KH; Chang KS; Hou CP; Feng TH; Juang HH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31861435
[TBL] [Abstract][Full Text] [Related]
14. Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer.
Liu P; Wu L; Chand H; Li C; Hu X; Li Y
Life Sci; 2020 Nov; 261():118311. PubMed ID: 32861793
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways.
Chiang KC; Tsui KH; Chung LC; Yeh CN; Feng TH; Chen WT; Chang PL; Chiang HY; Juang HH
Sci Rep; 2014 Jul; 4():5511. PubMed ID: 24981574
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of bladder cancer invasion by Sp1-mediated BTG2 expression via inhibition of DNA methyltransferase 1.
Devanand P; Kim SI; Choi YW; Sheen SS; Yim H; Ryu MS; Kim SJ; Kim WJ; Lim IK
FEBS J; 2014 Dec; 281(24):5581-601. PubMed ID: 25284287
[TBL] [Abstract][Full Text] [Related]
17. Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Xue Y; Li L; Zhang D; Wu K; Guo P; Zeng J; Wang X; He D
Oncol Rep; 2010 Dec; 24(6):1551-9. PubMed ID: 21042751
[TBL] [Abstract][Full Text] [Related]
18. TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer.
Yan L; Li Q; Yang J; Qiao B
J Cell Biochem; 2018 Feb; 119(2):1791-1803. PubMed ID: 28799673
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of the p53-inducible antiproliferative gene BTG2 in hepatocellular carcinoma is associated with overexpression of the cell cycle-related proteins.
Zhang Z; Chen C; Wang G; Yang Z; San J; Zheng J; Li Q; Luo X; Hu Q; Li Z; Wang D
Cell Biochem Biophys; 2011 Sep; 61(1):83-91. PubMed ID: 21327578
[TBL] [Abstract][Full Text] [Related]
20. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
